Note: Please read our disclaimer at the bottom of the article.
#ATG 🙌 #BOP 🚀 Nation Update❤️️
Hi, I’m Paul Mampilly.
Welcome to my company's Substack, where we provide daily coverage of #OGI (opportunity, growth, and innovation) market trends, macro level analysis, and stock picks.
Like our name suggests, at ATG Digital, we go Against the Grain to support everyday people on their investing journeys.
ATG also represents seeing the world for what is abundantly clear to see — an opportunity for incredible growth and the BRIGHT and PROSPEROUS future that lies ahead.
To aid you on your journey to financial freedom, we have five paid plans starting at $9.99 for you to consider.
With a subscription you get:
Premium Content: Weekly market and stock updates via email.
Stock Picking Guidance: Flash (buy/sell) alerts.
Model Portfolio Access: Access to LIVE portfolios.
Webinars: Private events with the team selected by you.
Just visit atgdigital.media to see which plan is the best fit for your journey!
Substack 🥞 subscribers: 6,322
We Just Bagged a 238% Winner! 🤑
Today, Platinum Tier members had the chance to capture a triple-digit profit in an options trade — in under three months!
Take a look:
Congratulations to everyone who profited from this trade! 🥂
(If you scored a win, we’d love to hear your story in the comments below!)
This was the result of a short-term trading strategy designed to capture explosive moves in the market . . .
We’re talking quick “in-and-out” trades that can amplify returns fast when managed carefully.
Enjoy trades like this delivered directly to you (via email and sms) by subscribing to our options trading Platinum Tier. 👇
New to options trading or need a refresher?
Don’t worry — we got you covered with a special deal! 👇
Celebrate With Us: 🎉 25% Off the Options Course!
To celebrate our latest winner, we’re gifting you our Options Trading 101 course at a 25% discount during the next 24 hours only.
Just click the button below to automatically receive your discount.
This course breaks down options trading in plain English with no jargon or complex formulas.
Just clear, simple explanations so you can start trading with confidence. 💪
It’s perfect for beginners who want to learn the fundamentals of the strategy behind our recent 238% gain.
But don’t wait — this special offer vanishes in 24 hours. ⏳
Dan: Handle Carefully ⚠️ Explosive Upside
Imagine discovering a tiny company before Wall Street catches on . . .
One with breakthrough treatments, explosive revenue growth, and the capability to transform an entire industry.
That’s why we track megatrends like cryptocurrency, rare metals, biotechnology, and the “Made-in-America” trade.
These aren’t just passing fads . . .
We believe they’re powerful tailwinds shaping the future, so we can’t help but feel very bullish on them!
Some of our positions in these sectors are performing exceptionally well across our ATG Digital model portfolios.
And while all of our portfolios provide exposure to these themes, our Diamond Tier houses the bigger, bolder bets.
High Risk, High Reward 🎯
Our Diamond Tier model portfolio pursues high-risk, high-reward opportunities in micro-cap stocks.
These small companies are typically valued under $1 billion, flying under Wall Street’s radar.
While they can deliver life-changing gains, they’re extremely volatile.
In other words, they’re not for everyone.
But if you can stomach the swings, the rewards can be enormous!
With our lead analyst Paul Mampilly’s 30+ years of investing expertise and Wall Street background in biotech, we’re not just guessing — we’re uncovering hidden gems.
Here’s one with explosive upside you don’t want to miss . . . 👇
An Industry Innovator 🧬
Travere Therapeutics Inc. (Nasdaq: TVTX) is a high-potential rare find! 🔍
This small biotech is shifting from a mixed rare-disease biotech portfolio into a focused renal care leader.
It’s anchored by its breakthrough drug Filspari (sparsenten), used for nephropathy.
Just last week, Filspari won FDA approval as the only Dual Endothelin Angiotensin Receptor Antagonist for the treatment of IgA nephropathy.
The FDA loosened restrictions, reducing the frequency of liver function monitoring to every three months from the onset of treatment with Filspari.
The FDA also removed the embryo-fetal toxicity monitoring requirement.
This reflects Filspari’s strong safety profile across clinical and real-world use.
It also provides easier access for patients, paving the way for Filspari to become a foundational treatment for people living with IaG nephropathy.
Growth Numbers That Turn Heads 👀
Since Filspari’s full FDA approval a year ago, the company doubled down on it, selling other drugs to streamline operations and fuel growth.
The strategy is working — by concentrating fully on Filspari, $TVTX trimmed costs and is now growing:
💹 Second quarter (Q2) 2025 U.S. net sales of Filspari grew 165% year over year (YoY) to $71.9 million with 745 new patient start forms.
💹 Total company revenue surged 110% YoY to$114.4 million.
💹 Cash on hand: $319.5 million — allowing plenty of runway.
With a current market cap of just $1.6 billion, $TVTX has massive room to run, in our view!
We’re up about 102% since adding this position to the Diamond Tier.
And while triple-digit gains are exciting, our eyes are on the next potential quadruple-digit winner!
That said, we’re holding this position for larger potential gains.
Is Diamond Tier Right for You? 💎
This tier isn’t for the faint of heart . . .
These stocks can swing wildly.
Losses can be steep, but so can the upside.
But if you’re the kind of investor who’s willing to take calculated risks in pursuit of extraordinary gains, this could be the perfect fit for you!
Members enjoy live trade recommendations, weekly portfolio updates and macro commentary, and insights into companies that could be future industry leaders, like $TVTX.
Just click the button below to get exposure! 👇
#OGI100: Tuesday, September 2, 2025
The #OGI100 is up 1.90% today.
Created on September 22, 2022, the #OGI100 is an index/portfolio comprised of opportunity, growth, innovation, and crypto-related investments.
Our goals with the #OGI100 are twofold . . .
First, we want readers to get a sense of what our investments are doing in the market, because they can sometimes perform very differently than traditional indices (like the S&P 500 or Nasdaq 100).
Second, we’d like to eventually turn the #OGI100 into an exchange-traded fund (ETF).
That way, instead of owning hundreds of growth stocks, you can get exposure to ATG Digital thinking — in opportunity, growth, innovation, and crypto — all in one place.
To learn more or to express your support for the launch of an ETF (by completing a poll), click here.
Tomorrow: Dean reveals his go-to play for the gold surge! 📈
HUGE Opportunity Alert! 🤑
Looking for the next potential breakout stock under $10?
You’ve come to the right place!
Paul uncovered a dirt-cheap stock with massive upside potential — and he dropped it in his latest YouTube video.
It was up as much as 30% today! 🚀
This could be one of those rare setups you’ll wish you caught early.
Don’t miss it — click below to watch now.
Loving the content? Leave a “👍” and drop a comment to share your top takeaways!
On Tuesday, September 2, 2025, subscribe to our YouTube channel. 🔔
❤️ This Substack was made — by US, for YOU — with love. ❤️
Questions? Concerns? 🤔 Look Below 👇
Have questions or trouble accessing your account? Please reach out to us at info@atgdigital.media or schedule a call, and our Customer Support team will be happy to help.
You can also check our FAQ page on our website for an up-to-date list of questions and answers. Your question may have been addressed there.
*Please be advised that customer support calls are limited to 15 minutes and will strictly cover your membership subscription and billing needs only. Any calls that are disrespectful in nature may be subject to immediate termination.
Join us, be #BOP 🚀, be #StrongHands 🙌, #GoATG! ️️❤️️
Disclaimer/Legal Stuff Written in Plain English
What you read/watch/hear is OPINION, not financial/investment advice. Treat it no different than when you read/watch/hear your favorite author/YouTuber/podcaster. Despite our best efforts, we get things wrong and make mistakes. Investing is risky. There is no guarantee you will make money. Your investments may lose value. That’s RISK. Past performance is no guarantee of future results. Employees, contractors, and owners of ATG Digital, LLC own/trade/transact in the stocks, options, and crypto that are the subject of our trade alerts, updates, reports, and commentaries. We cannot give you personalized financial advice because we are NOT financial advisors. It’s on you to decide how much/when/what to buy/sell based on YOUR financial needs, plans, and risk preferences. There are no guarantees. Loss of your capital is an outcome that you should evaluate carefully with a financial advisor before you trade, speculate, or invest. It's your money and your responsibility.